Evidence map›Paper›PMID 37869669›Full record

ArticleFrontiers in microbiology2023

Maternal supplementation with

Renqiang Yu, Yizhe Ma, Zichen Luo, Ce Qi, Anni Xie, Yifan Jiang, Baoli Zhu, Jin Sun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Renqiang YuDepartment of Neonatology, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Wuxi, China.
Yizhe MaDepartment of Pediatric, Jiangyin People's Hospital of Nantong University, Wuxi, China.
Zichen LuoDepartment of Neonatology, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Wuxi, China.
Ce QiInstitute of Nutrition and Health, Qingdao University, Qingdao, China.
Anni XieDepartment of Neonatology, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Wuxi, China.
Yifan JiangSchool of Medicine, Nantong University, Nantong, China.
Baoli ZhuDepartment of Neonatology, Wuxi Maternity and Child Health Care Hospital, Women's Hospital of Jiangnan University, Wuxi, China.
Jin SunInstitute of Nutrition and Health, Qingdao University, Qingdao, China.
Jiangnan University · CNNantong University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atopic dermatitis (AD) has increased rapidly with rapid urbanization; however, the treatment options for AD are lacking because the commonly used therapies can only alleviate symptoms. Methods: First, a randomized, double-blind, placebo-controlled intervention study will be conducted on 340 pregnant females with babies at high risk for AD. These subjects will be randomly divided into four groups of different doses of Discussion: The primary outcome is the cumulative incidence of AD at 24 months after maternal consumption of Clinical trial registration: https://www.chictr.org.cn/, identifier [ChiCTR2300075611].

Indexed as

atopic dermatitisbreast milkinfantLimosilactobacillus reuterimicrobiotaprobiotics

Identifiers

PMID37869669
PMCPMC10588667
OpenAlexW4387374781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.